ResearcherIndiana University HealthNo recent work listed
Eugene P. Ceppa
Matched on ORCID iD 0000-0002-8368-2232; OpenAlex author ID A5088769393. Sources: OpenAlex.
Their work
- Papers
- 14 (first author 1, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 31
2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: 2 papers · 2018: 1 paper · 2019: 2 papers · 2020: 3 papers · 2021: 1 paper · 2022: none · 2023: 2 papers
Papers 14
- Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening? Last author DOI 10.1002/jso.27289↗
- Neoadjuvant therapy at local versus outside institutions does not adversely impact surgical timing or long-term outcomes in patients with pancreatic adenocarci… Co-author DOI 10.1016/j.surg.2022.06.046↗
- Profiling of Adipose and Skeletal Muscle in Human Pancreatic Cancer Cachexia Reveals Distinct Gene Profiles with Convergent Pathways. Co-author DOI 10.3390/cancers13081975↗
- Hepatic Steatosis After Neoadjuvant Chemotherapy for Pancreatic Cancer: Incidence and Implications for Outcomes After Pancreatoduodenectomy. Co-author DOI 10.1007/s11605-020-04723-2↗
- Preoperative imaging characteristics predict poor survival and inadequate resection for left-sided pancreatic adenocarcinoma: a multi-institutional analysis. Co-author DOI 10.1016/j.hpb.2019.12.012↗
- Pancreatic Adenocarcinoma Causing Necrotizing Pancreatitis: Not as Rare as You Think? Co-author DOI 10.1016/j.jss.2019.12.036↗
- The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy. Co-author DOI 10.1002/jcsm.12461↗
- Are BRCA1 and BRCA2 gene mutation patients underscreened for pancreatic adenocarcinoma? Last author DOI 10.1002/jso.25376↗
- Laparoscopic distal pancreatectomy for pancreatic cancer is safe and effective. Last author DOI 10.1007/s00464-017-5633-7↗
- Prospective Evaluation of Associations between Cancer-Related Pain and Perineural Invasion in Patients with Resectable Pancreatic Adenocarcinoma. Co-author DOI 10.1007/s11605-017-3513-z↗
- Reduced morbidity with minimally invasive distal pancreatectomy for pancreatic adenocarcinoma. First author DOI 10.1016/j.hpb.2017.01.014↗
- Significance of Portal Vein Invasion and Extent of Invasion in Patients Undergoing Pancreatoduodenectomy for Pancreatic Adenocarcinoma. Co-author DOI 10.1007/s11605-015-3005-y↗
- Extended distal pancreatectomy for pancreatic adenocarcinoma with splenic vein thrombosis and/or adjacent organ invasion. Co-author DOI 10.1016/j.amjsurg.2014.10.017↗
- Comparison of outcomes and the use of multimodality therapy in young and elderly people undergoing surgical resection of pancreatic cancer. Co-author DOI 10.1111/j.1532-5415.2011.03785.x↗
Closest collaborators
The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Michael Garrett House · 11 shared papers, 2015–2023 · strength 1.14
- Paper Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening? DOI 10.1002/jso.27289↗
- Paper Neoadjuvant therapy at local versus outside institutions does not adversely impact surgical timing or long-term outcome… DOI 10.1016/j.surg.2022.06.046↗
- Paper Pancreatic Adenocarcinoma Causing Necrotizing Pancreatitis: Not as Rare as You Think? DOI 10.1016/j.jss.2019.12.036↗
- Nicholas Joseph Zyromski · 11 shared papers, 2015–2023 · strength 1.14
- Paper Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening? DOI 10.1002/jso.27289↗
- Paper Neoadjuvant therapy at local versus outside institutions does not adversely impact surgical timing or long-term outcome… DOI 10.1016/j.surg.2022.06.046↗
- Paper Pancreatic Adenocarcinoma Causing Necrotizing Pancreatitis: Not as Rare as You Think? DOI 10.1016/j.jss.2019.12.036↗
- Christian Max Schmidt · 9 shared papers, 2015–2023 · strength 0.85
- Paper Neoadjuvant therapy at local versus outside institutions does not adversely impact surgical timing or long-term outcome… DOI 10.1016/j.surg.2022.06.046↗
- Paper Pancreatic Adenocarcinoma Causing Necrotizing Pancreatitis: Not as Rare as You Think? DOI 10.1016/j.jss.2019.12.036↗
- Paper Profiling of Adipose and Skeletal Muscle in Human Pancreatic Cancer Cachexia Reveals Distinct Gene Profiles with Conver… DOI 10.3390/cancers13081975↗
- Alexandra M. Roch · 7 shared papers, 2015–2023 · strength 0.76
- Paper Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening? DOI 10.1002/jso.27289↗
- Paper Neoadjuvant therapy at local versus outside institutions does not adversely impact surgical timing or long-term outcome… DOI 10.1016/j.surg.2022.06.046↗
- Paper Preoperative imaging characteristics predict poor survival and inadequate resection for left-sided pancreatic adenocarc… DOI 10.1016/j.hpb.2019.12.012↗
- Trang K. Nguyen · 3 shared papers, 2020–2023 · strength 0.47
- Paper Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening? DOI 10.1002/jso.27289↗
- Paper Neoadjuvant therapy at local versus outside institutions does not adversely impact surgical timing or long-term outcome… DOI 10.1016/j.surg.2022.06.046↗
- Paper Hepatic Steatosis After Neoadjuvant Chemotherapy for Pancreatic Cancer: Incidence and Implications for Outcomes After P… DOI 10.1007/s11605-020-04723-2↗
- Rachel C. Kim · 2 shared papers, 2023 · strength 0.37
- Christopher M. Schmidt · 2 shared papers, 2019–2023 · strength 0.29
- Safi Shahda · 2 shared papers, 2019–2021 · strength 0.18
- Yunlong Liu · 2 shared papers, 2019–2021 · strength 0.18
- Xiaoling Zhong · 2 shared papers, 2019–2021 · strength 0.18
- Teresa A Zimmers · 2 shared papers, 2019–2021 · strength 0.18
- Rosalie A. Carr · 2 shared papers, 2017–2019 · strength 0.17
- Henry Anthony Pitt · 2 shared papers, 2017–2018 · strength 0.16
- Kyle A. Lewellen · 1 shared paper, 2020 · strength 0.12
- Ashok Narasimhan · 1 shared paper, 2021 · strength 0.10
- Joshua K. Kays · 1 shared paper, 2021 · strength 0.10
- Mark A. Tann · 1 shared paper, 2020 · strength 0.10
- Katelyn F. Flick · 1 shared paper, 2020 · strength 0.10
- Farzad Alemi · 1 shared paper, 2020 · strength 0.10
- Paul Hansen · 1 shared paper, 2020 · strength 0.10
- Adnan A. Alseidi · 1 shared paper, 2020 · strength 0.10
- Horacio J. Asbun · 1 shared paper, 2020 · strength 0.10
- Zeljka Jutric · 1 shared paper, 2020 · strength 0.10
- Susanne Gray Warner · 1 shared paper, 2020 · strength 0.10
- Taylor Sohn Riall · 1 shared paper, 2017 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.